Impact Factor
3.98
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.39
1,978 total citations
h5-index
50
h5 depth signal
Cited share
80.0%
385 of 481
Total citations
1,978
Citation footprint
Metric signal
4.64
External metric anchor
Self-citation
2.7%
54 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Germany
692
Italy
295
China
197
United States
183
Spain
112
Citing Fields of Research
Antibiotic & Antibacterial Agents
674
Virology
358
Bacteriology
180
Fungal Pathogenesis
156
Respiratory Support
152
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
7,964
Articles tracked across the journal lifetime
Indexed publication set
481
385 cited publications
Last 12 months
311
25.9 publications/month
Open access share
54.7%
170 OA publications in the last year
Leading citing country
Germany
692 citing publications
Leading citing field
Antibiotic & Antibacterial Agents
674 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1973-
v1n1, 1973-
Active Coverage
Research Focus & Classification
Indexed Subjects
Antibiotic & Antibacterial Agents
Issuing & Sponsoring Bodies
Contributor
Deutsche Gesellschaft für Infektiologie
Contributor
Paul-Ehrlich-Gesellschaft
Contributor
Società italiana di malattie infettive e tropicali
Contributor
Deutsche Sepsis-Gesellschaft
Broad Categories
Allergy and Immunology
Communicable Diseases
Antibiotic & Antibacterial Agents
Virology
Fungal Pathogenesis
Mycobacterial Diseases
Respiratory Support
MeSH Descriptors
Infections
Infections
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s15010-026-03022-3
Open DOI
Epidemiological and sociodemographic profile of Mpox in Brazilian Amazon: a cross-sectional study
Background: The Mpox outbreak was characterized by viral transmission within sexual networks and atypical clinical presentations, requiring regional epidemiological evaluations. This study aimed to describe the sociodemographic profile, ...
02
DOI 10.1007/s15010-026-03020-5
Open DOI
Serum hepcidin as a host-derived biomarker of disease severity and risk stratification in tuberculosis
03
DOI 10.1007/s15010-026-02988-4
Open DOI
Outcomes of non-tuberculous mycobacterial infection of the bone, joint and soft tissue: a seven-year multicentre retrospective study
Purpose: Extrapulmonary nontuberculous mycobacterial (EPNTM) infections of bone, joint, and soft tissue are difficult to treat and lack species-specific outcome data. We sought to describe antimicrobial regimens and surgical management b...
04
05
DOI 10.1007/s15010-026-03003-6
Open DOI
Clinical significance of human rhino-/enterovirus co-detection in pediatric Mycoplasma pneumoniae infections
Purpose: To determine whether upper respiratory tract co-detection of human rhino-/enterovirus is associated with a distinct clinical phenotype in children with Mycoplasma pneumoniae infection. Methods: We analyzed 236 children with M. p...
06
DOI 10.1007/s15010-026-03014-3
Open DOI
Cardiac injury in children with severe hand, foot and mouth disease: risk factors and clinical outcomes
07
DOI 10.1007/s15010-026-03011-6
Open DOI
Healthcare pathways and outpatient management prior to community-acquired sepsis hospitalization in Germany, 2016–2019
Purpose: Sepsis often presents with non-specific symptoms that delay diagnosis and treatment. This study characterized pre-hospital outpatient and emergency care among patients with community-acquired sepsis (CAS) in Germany prior to hos...
08
09
DOI 10.1007/s15010-026-03013-4
Open DOI
Gut microbiota dysbiosis in patients with sepsis: a meta-analysis of microbial diversity and taxonomic abundance
10
Bibliographical & Catalog Notes
Some vols. have supplements.
Also issued online.
Text in German or English, with summaries in both languages.
Official organ of the Paul Ehrlich Gesellschaft and the Deutsche Gesellschaft für Infektiologie, 1973- ; and of Deutsche Gesellschaft für Infektiologie (DGI), the Italian Society of Infectious and Tropical Diseases (SIMIT), the Paul Ehrlich Society for Chemotherapy (PEG) and the German Sepsis Society (DSG), <2007->